Description: Avicanna Inc. focuses on the research and development, cultivation, manufacture, and commercialization of plant-derived cannabinoid-based products and extracts in North America, Latin America, Europe, and Asia. It intends to offer plant-derived cannabinoid pharmaceuticals, phyto-therapeutics, derma-cosmetics, and extracts. The company was founded in 2016 and is headquartered in Toronto, Canada.
Home Page: www.avicanna.com
480 University Avenue
Toronto,
ON
M5G 1V2
Canada
Phone:
647 243 5283
Officers
| Name | Title |
|---|---|
| Mr. Aras Azadian B.Econ, Mba | Co-Founder, CEO & Director |
| Dr. Frantz Le Devedec | Exec. VP of R&D |
| Mr. Roland Alvarez | SVP of Technical Operations |
| Ms. Ivana Maric | Exec. VP of Marketing |
| Dr. Carlos Enrique Maldonado Muete | SVP of Clinical Devel. |
| Ms. Caitlin Johnston | Sr. VP of Strategic Partnerships & Patient Access |
Exchange: OTCQX
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 9.3215 |
| Price-to-Sales TTM: | 4.511 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 124 |